Carly Nelson, APRN
Nurse Practitioner · Las Vegas, NVNPI 1770977407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $993 and has fallen 97.8% since, to $22 in 2025. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$652
- Exeltis, USA Inc.$533
- Daiichi Sankyo Inc.$367
- Astellas Pharma US Inc$306
- Therapeuticsmd, Inc.$274
- Hologic Sales And Service, LLC$216
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,38598%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $652 |
| Exeltis, USA Inc. | 29 | $533 |
| Daiichi Sankyo Inc. | 17 | $367 |
| Astellas Pharma US Inc | 10 | $306 |
| Therapeuticsmd, Inc. | 15 | $274 |
| Hologic Sales And Service, LLC | 2 | $216 |
| Mayne Pharma Commercial LLC | 8 | $176 |
| Myriad Women's Health, Inc. | 1 | $136 |
| Pfizer | 6 | $135 |
| Organon | 6 | $90 |
| Agile Therapeutics, Inc. | 4 | $66 |
| Mylan Pharmaceuticals Inc. | 4 | $63 |
| Medtronic | 2 | $57 |
| Evofem Biosciences, Inc. | 3 | $48 |
| Avion Pharmaceuticals | 3 | $45 |
| Bayer | 3 | $43 |
| Medicem Inc. | 3 | $40 |
| Exact Sciences | 2 | $36 |
| Merck | 2 | $36 |
| Coopersurgical, Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Gynesonics, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $16 |
| Aspira Women's Health Inc | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $14 |
| Optumhealth Care Solutions, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$159
- myRisk$136
- INJECTAFER$125
How this compares
$3,470 in reported general payments places this provider in the 90th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Las Vegas
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
- Shannon SouthwickLas Vegas$32K
- Bonnie KwanLas Vegas$30K
- Amanda RalphLas Vegas$26K
- Teodoro AgtayLas Vegas$25K
- Katherine WhitmireLas Vegas$18K
- Jennifer WalshLas Vegas$18K
- Andrew VolinLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.